Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function
Mariona Guitart‐Mampel, Pedro Urquiza, Jordana I. Borges, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1552-1552
Open Access | Times Cited: 14

Showing 14 citing articles:

Managing Doxorubicin Cardiotoxicity: Insights Into Molecular Mechanisms and Protective Strategies
Adnan Taan Al khafaji, Ali Barakat, Akram Joudah shayyal, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access | Times Cited: 1
Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome
Kexin Ma, Weifang Gao, Huazhou Xu, et al.
Journal of the Renin-Angiotensin-Aldosterone System (2022) Vol. 2022
Open Access | Times Cited: 35
Right ventricle remodeling in chronic thromboembolic pulmonary hypertension
Jixiang Liu, Peiran Yang, Han Tian, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 2, pp. 125-133
Open Access | Times Cited: 18
Mitochondrial microRNAs Are Dysregulated in Patients with Fabry Disease
Jessica Gambardella, Antonella Fiordelisi, Daniela Sorriento, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 72-78
Open Access | Times Cited: 16
Heart Failure with Improved Ejection Fraction: Insight into the Variable Nature of Left Ventricular Systolic Function
Maciej Wybraniec, Michał Orszulak, Klaudia Męcka, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 21, pp. 14400-14400
Open Access | Times Cited: 16
RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting
Anastasios Lymperopoulos, Jordana I. Borges, Renee A. Stoicovy
Biochemical Pharmacology (2023) Vol. 218, pp. 115904-115904
Open Access | Times Cited: 10
Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
Jordana I. Borges, Krysten E. Ferraino, Natalie Cora, et al.
Journal of Cardiovascular Pharmacology (2022) Vol. 80, Iss. 3, pp. 386-392
Open Access | Times Cited: 14
Cardiovascular angiotensin II type 1 receptor biased signaling: Focus on non-Gq-, non-βarrestin-dependent signaling
Anastasios Lymperopoulos, Jordana I. Borges, Alexandra Carbone, et al.
Pharmacological Research (2021) Vol. 174, pp. 105943-105943
Closed Access | Times Cited: 18
Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States
Tomoko Ichiki, Atsushi Jinno, Yoshihisa Tsuji
Biology (2022) Vol. 11, Iss. 6, pp. 859-859
Open Access | Times Cited: 12
Improving effects of eplerenone on atrial remodeling induced by chronic intermittent hypoxia in rats
Yang Yu, Yongzheng Liu, Changhui Ma, et al.
Cardiovascular Pathology (2022) Vol. 60, pp. 107432-107432
Open Access | Times Cited: 6
Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
Moritz Schnelle, Andreas Leha, Abass Eidizadeh, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2796-2796
Open Access | Times Cited: 4
The role of β2-AR/PI3K/AKT pathway in the proliferation, migration and invasion of THLE-2 cells induced by nicotine
Yuqin Xu, Zihan He, Zihan Rao, et al.
Toxicology (2024) Vol. 508, pp. 153924-153924
Closed Access
Attenuation of Hypertension and protection of vascular inflammation in hyperaldosteronism: GPER1 as potential therapeutic candidate when MR antagonist is less satisfying?
Yulian Lai, Ziwei Tang, Zhipeng Du, et al.
Endocrine (2024)
Open Access
Potential Ameliorating Role of Spironolactone in Trastuzumab-induced Cardiotoxicity: A Narrative Review
Amir Ghabousian, Azin Alizadehasl, Niloufar Ansari, et al.
International Journal of Medical Toxicology and Forensic Medicine (2022) Vol. 12, Iss. 2, pp. 36127-36127
Open Access
Page 1

Scroll to top